These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 6813472)

  • 21. [Gold therapy of rheumatic diseases].
    Berndt H
    Z Arztl Fortbild (Jena); 1987; 81(9):416. PubMed ID: 3114970
    [No Abstract]   [Full Text] [Related]  

  • 22. Management of pemphigus with gold compounds: a long-term follow-up report.
    Penneys NS; Eaglstein WH; Frost P
    Arch Dermatol; 1976 Feb; 112(2):185-7. PubMed ID: 822783
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo and in vitro effects of gold salts on lymphocyte transformation responses and antibody dependent cell-mediated cytotoxicity.
    Davis P; Percy JS; Russell AS
    J Rheumatol; 1979; 6(5):527-33. PubMed ID: 118255
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IV N-acetylcysteine treatment of hematologic reactions to chrysotherapy.
    Godfrey NF; Peter A; Simon TM; Lorber A
    J Rheumatol; 1982; 9(4):519-26. PubMed ID: 6813467
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gold distribution in whole blood during chrysotherapy.
    Smith PM; Smith EM; Gottlieb NL
    J Lab Clin Med; 1973 Dec; 82(6):930-7. PubMed ID: 4202278
    [No Abstract]   [Full Text] [Related]  

  • 26. Long-term chrysotherapy in rheumatoid arthritis.
    Srinivasan R; Miller BL; Paulus HE
    Arthritis Rheum; 1979 Feb; 22(2):105-10. PubMed ID: 105739
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence for immunostimulatory effects of intramuscular gold in patients with rheumatoid arthritis: correlation with skin reactions.
    Ernestam S; Lampa J; Rogberg S; Rönnelid J; Klareskog L; Hafström I
    J Rheumatol; 2003 Aug; 30(8):1748-55. PubMed ID: 12913930
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of longterm treatment with auranofin and gold sodium thiomalate on immune function in the dog.
    Bloom JC; Thiem PA; Halper LK; Saunders LZ; Morgan DG
    J Rheumatol; 1988 Mar; 15(3):409-17. PubMed ID: 3132555
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiarthritic synergism of combined oral and parenteral chrysotherapy. II. Increased inhibition of activated leukocyte oxygen burst by combined gold action.
    Finkelstein AE; Ladizesky M; Borinsky R; Kohn E; Ginsburg I
    Inflammation; 1988 Aug; 12(4):383-90. PubMed ID: 2844672
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Use of colloid gold in the treatment of rheumatoid arthritis].
    Popović M; Davis P
    Vojnosanit Pregl; 1978; 35(4):284-9. PubMed ID: 100966
    [No Abstract]   [Full Text] [Related]  

  • 31. Gold and modulation of the immune response.
    Harth M
    J Rheumatol Suppl; 1979; 5():7-11. PubMed ID: 385876
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiarthritic synergism of combined oral and parenteral chrysotherapy. I. Studies in adjuvant-induced arthritis in rats.
    Finkelstein AE; Ladizesky M; Borinsky R; Kohn E; Ginsburg I
    Inflammation; 1988 Aug; 12(4):373-82. PubMed ID: 3139562
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Indications and contraindications for systemic gold therapy].
    Schattenkirchner M
    Wien Klin Wochenschr Suppl; 1984; 156():3-7. PubMed ID: 6442054
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Comparative study of the effects of auranofin and aurothiomalate on laboratory and clinical indicators in patients with rheumatoid arthritis].
    Vlak T; Stambuk B
    Reumatizam; 1998; 46(1):7-19. PubMed ID: 9921004
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The influence of cigarette smoking on blood gold distribution during chrysotherapy.
    James DW; Ludvigsen NW; Cleland LG; Milazzo SC
    J Rheumatol; 1982; 9(4):532-5. PubMed ID: 6813469
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Chrysotherapy and side effects (author's transl)].
    Eberl R
    Wien Klin Wochenschr Suppl; 1974; 25():3-22. PubMed ID: 4279096
    [No Abstract]   [Full Text] [Related]  

  • 37. Serum gold. II. Levels in rheumatoid arthritis.
    Rubinstein HM; Dietz AA
    Ann Rheum Dis; 1973 Mar; 32(2):128-32. PubMed ID: 4266407
    [No Abstract]   [Full Text] [Related]  

  • 38. Distribution of gold in serum erythrocytes and white blood cells after in vitro incubation and during chrysotherapy with different gold compounds.
    Herrlinger JD; Alsen C; Beress R; Hecker U; Weikert W
    J Rheumatol Suppl; 1982; 8():81-9. PubMed ID: 6813496
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chrysotherapy: pharmacological and clinical correlates.
    Lorber A; Simon TM; Leeb J; Carroll PE
    J Rheumatol; 1975 Dec; 2(4):401-10. PubMed ID: 1206672
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of auranofin dose regimen change upon cell-associated gold in rheumatoid arthritic patients.
    Walz DT; Griswold DE; DiMartino MJ; Bumbier EE
    J Rheumatol; 1981; 8(5):829-32. PubMed ID: 6796684
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.